Financials
Value Q1, 25Q2, 25 TTM Selling/general/admin expenses —— — Research & development —— — Operating income 318.8 M336.4 M 1.34 B Non-Operating Income, Total 33.3 M30.3 M 123.2 M Interest expense, net of interest capitalized 12.4 M12.3 M 50.5 M Non-Operating Income, excl. Interest Expenses 4.1 M2.9 M 10.8 M Unusual income/expense 16.8 M15.1 M 61.9 M Pretax income 323.2 M339.2 M 1.35 B Equity in earnings —— — Taxes 69.7 M73 M 295.1 M Non-controlling/minority interest 6.5 M5.6 M 24.8 M After tax other income/expense —— — Net income before discontinued operations 247 M260.6 M 1.03 B Discontinued operations —— — Net income 247 M260.6 M 1.03 B Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders 247 M260.6 M 1.03 B Basic earnings per share (Basic EPS) 4.765.04 19.93 Diluted earnings per share (Diluted EPS) 4.694.96 19.61 Average basic shares outstanding 51.88 M51.74 M — Diluted shares outstanding 52.7 M52.52 M — EBITDA 1.31 B1.33 B 5.3 B EBIT 1.28 B1.31 B 5.18 B Cost of revenue 18.3 M17.3 M 72 M Other cost of goods sold —— — Depreciation & amortization (cash flow) 25 M20.2 M 112.6 M